Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Commercial Sponsor
Breast Cancer Trials
Scientific Title
A randomised phase II trial evaluating the efficacy of a nivolumab monotherapy lead in “window†or commencement of nivolumab concurrently with paclitaxel and carboplatin as neoadjuvant therapy in early stage triple negative breast cancers